How many institutions held LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in Q2 2017?

76 institutional investors reported LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share for Q2 2017. Use the holders table for investor-level position and value details.

STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Q: What does CUSIP 34385P108 represent in this 13F holders report?

CUSIP 34385P108 is the security identifier for LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 34385P108

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 384,731,503
Total 13F shares: 26,292,789
Share change: -822,004
Total reported value: $106,212,221
Put/Call ratio: 60%
Price per share: $4.04
Number of holders: 76
Value change: -$4,700,293
Number of buys: 34
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 34385P108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	1.5%	5,755,753	$32,750,000	—	31 Mar 2017	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.1%	4,294,843	$24,438,000	—	31 Mar 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.59%	2,258,937	$12,849,000	—	31 Mar 2017	13F
Neuberger Berman Group LLC	13F	Company	0.5%	1,924,408	$10,950,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.47%	1,823,134	$10,373,000	—	31 Mar 2017	13F
ORBIMED ADVISORS LLC	13F	Company	0.45%	1,746,100	$9,935,000	—	31 Mar 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.4%	1,546,209	$8,798,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	0.31%	1,181,883	$6,725,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.16%	630,277	$3,587,000	—	31 Mar 2017	13F
WASATCH ADVISORS LP	13F	Company	0.16%	629,104	$3,580,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.12%	476,400	$2,711,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.12%	470,414	$2,677,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.1%	379,160	$2,157,000	—	31 Mar 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.08%	301,705	$1,716,000	—	31 Mar 2017	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.07%	283,361	$1,612,000	—	31 Mar 2017	13F
Healthcare Value Capital, LLC	13F	Company	0.07%	275,000	$1,565,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	218,321	$1,242,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.05%	206,572	$1,175,000	—	31 Mar 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	190,578	$1,084,000	—	31 Mar 2017	13F
FIC CAPITAL INC	13F	Company	0.05%	188,700	$1,074,000	—	31 Mar 2017	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.05%	176,551	$1,005,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	0.04%	164,219	$934,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	150,332	$855,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	145,063	$825,000	—	31 Mar 2017	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	143,572	$817,000	—	31 Mar 2017	13F
Intellectus Partners, LLC	13F	Company	0.04%	135,689	$772,000	—	31 Mar 2017	13F
Paloma Partners Management Co	13F	Company	0.03%	125,000	$711,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	124,446	$708,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	107,587	$611,000	—	31 Mar 2017	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.03%	100,000	$569,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	79,707	$454,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	75,735	$431,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	58,487	$333,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	55,663	$317,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.01%	54,400	$310,000	—	31 Mar 2017	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.01%	45,664	$260,000	—	31 Mar 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.01%	45,633	$260,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	42,629	$243,000	—	31 Mar 2017	13F
FALCON POINT CAPITAL, LLC	13F	Company	0.01%	40,661	$231,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.01%	40,101	$229,000	—	31 Mar 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	38,600	$220,000	—	31 Mar 2017	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	32,202	$183,000	—	31 Mar 2017	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.01%	27,408	$156,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	25,521	$146,000	—	31 Mar 2017	13F
STONERIDGE INVESTMENT PARTNERS LLC	13F	Company	0.01%	25,293	$144,000	—	31 Mar 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	23,700	$135,000	—	31 Mar 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.01%	23,549	$133,000	—	31 Mar 2017	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.01%	20,500	$117,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0%	18,885	$107,000	—	31 Mar 2017	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	17,907	$102,000	—	31 Mar 2017	13F

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2017

As of 30 Jun 2017, STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,292,789 shares. The largest 10 holders included LEVIN CAPITAL STRATEGIES, L.P., PRIMECAP MANAGEMENT CO/CA/, Russell Investments Group, Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C., Neuberger Berman Group LLC, BlackRock Inc., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. This page lists 76 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

-2

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.